Mario Gabelli’s Latest Moves: Xyratex Ltd. (XRTX), BioScrip Inc (BIOS), & LIN MEDIA LLC (LIN)

In another round of filing with the Securities and Exchange Commission, Mario Gabelli has revealed his latest moves. Together with GAMCO Investors and its subsidiaries, Gabelli has dumped the 1.54 million shares of Xyratex Ltd. (NASDAQ:XRTX) they have bought earlier this year. In another move, Gabelli has massively increased his fund’s investment in BioScrip Inc (NASDAQ:BIOS) to 3.69 million shares, which account for 5.42% of the company’s common shares. Last but not least, Gabelli and GAMCO have increased their stake in LIN MEDIA LLC (NYSE:LIN) to 2.92 million shares or 8.47% of the total number of shares outstanding.

Mario Gabelli

Xyratex Ltd. (NASDAQ:XRTX) is held in high regards by Matthew Drapkin and Steven R. Becker, who have built a new position for their fund in the fourth quarter of 2013. Becker Drapkin Management reported ownership of 1.22 million shares valued at $16.2 million in its latest 13F filing. Paul Glazer, the manager of Glazer Capital, is also betting big, having acquired approximately 489,200 shares for his fund in the same period, a position worth around $6.5 million.

Xyratex Ltd. (NASDAQ:XRTX) is a provider of modular solutions for data storage devices. The company has a market cap of $364 million and does not pay a dividend. So far this year, the stock has been trending sideways, close to the start-of-the-year price of $13.29 per share. With a current price of $13.24, the stock is traded at a forward Price to Earnings (P/E) ratio of 17.42. For the three months ending Novemeber 30, Xyratex posted revenues of $185 million and a loss per share of $0.76. Previous quarter is expected to bring $166 million in revenue and a loss per share of $0.1.

Phil Frohlich is also betting big on BioScrip Inc (NASDAQ:BIOS), with his fund, Prescott Group Capital Management, having increased its stake by 128% during the Q4 of 2013. In its latest 13F report, Prescott has revealed ownership of 2.43 million shares worth approximately $18 million. Alan Fournier is also a fan, having upped his fund’s stake by 44% in the same period. Pennant Capital Management holds more than 5 million shares reportedly worth $37.7 million.

A provider of home health care services, BioScrip Inc (NASDAQ:BIOS) has a market cap of $473 million and does not pay a dividend. The company announced revenues of $243 million and a loss of $0.16 per share for the three months ending December 31, 2013. For the first quarter of 2014, it is expected to register $223 million in revenues and a loss per share of $0.03. The stock has entered a downtrend following the $17.62 high in July 2013 and has been trending sideways since the start of 2014. With a current price of $6.93 per share, the stock is trading at a forward P/E ratio of 49.50. It is recommended as a Buy and Strong Buy.

Keith Meister is also very bullish on LIN MEDIA LLC (NYSE:LIN) and has increased his fund’s stake by 69% during the fourth quarter of 2013. Corvex Capital reported ownership of 949,600 shares worth approximately $27.2 million. Bart Baum has massively increased his fund’s investment in Lin Media during the same period, taking it to 726,100 shares reportedly worth $20.8 million.

LIN MEDIA LLC (NYSE:LIN) is a local multimedia company that operates in the United States. It has a market cap of $922 million and does not pay a dividend. The stock is traded at a trailing P/E ratio of 9.xx, approximately twice the industry average of 4.20. The company has posted revenues of $184 million and earnings of $0.1 per share for the fourth quarter of 2013. Analysts’ estimates for the first quarter of 2014 are as follows: revenues of $165 million and EPS of $0.05.

Disclosure: none.

Recommended reading:

Telephone & Data Systems, Inc. (TDS) And Two Other Moves From Mario Gabelli and GAMCO Investors

Mario Gabelli Reveals Latest Moves In Its Equity Portfolio

Cadence Pharmaceuticals, Inc. (CADX), Griffin Land & Nurseries, Inc. (GRIF) and Three Other Moves From Mario Gabelli and GAMCO Investors

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!